Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
NET INCOME	$ 84,796	$ 96,734	$ 70,061
ADJUSTMENTS TO RECONCILE NET INCOME TO NET CASH PROVIDED BY OPERATING ACTIVITIES:
Depreciation and amortization	40,394	40,685	40,286
Earnings from equity-accounted investments	(639)	(452)	(298)
Fair value adjustment	519	248	(55)
Interest payable	1,829	1,283	2,100
Facility fee amortized	138	208	738
Gain on release from accumulated other comprehensive income (Note 7)	(2,176)
Gain on fair value of Transact24 (Note 3)	(1,909)
Profit on disposal of property, plant and equipment	(286)	(296)	(434)
Loss on deconsolidation of subsidiaries and business (Note 19)			55
Stock-based compensation charge, net of forfeitures (Note 18)	3,598	3,195	3,718
Fair value of BEE equity instruments granted (Note 17)			11,268
(Increase) Decrease in accounts and finance loans receivable, and pre-funded grants receivable	(3,401)	1,399	(101,447)
Decrease (Increase) in inventory	1,001	(3,846)	780
(Decrease) Increase in accounts payable and other payables	(7,840)	(850)	12,671
Increase in taxes payable	763	606	5,523
Decrease in deferred taxes	(235)	(3,656)	(7,821)
NET CASH PROVIDED BY OPERATING ACTIVITIES	116,552	135,258	37,145
CASH FLOWS FROM INVESTING ACTIVITIES
Capital expenditures	(35,797)	(36,436)	(23,906)
Proceeds from disposal of property, plant and equipment	1,349	857	2,990
Acquisitions, net of cash acquired (Note 3)	(15,767)
Acquisition of available for sale securities (Note 7)	(8,900)
(Acquisition of equity of)/Capital reduction/ repayment of loan by equity-accounted investment		(13,200)	539
Proceeds from sale of business (Note 19)		1,895	186
Net cash outflow from sale of MediKredit (Note 19)			(669)
Other investing activities, net	(5)	(29)	570
Net change in settlement assets (Note 2)	53,364	(33,870)	11,053
NET CASH USED IN INVESTING ACTIVITIES	(5,756)	(80,783)	(9,237)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issue of common stock (Note 14 and 18)	111,444	2,045	198
Acquisition of treasury stock (Note 14)	(26,637)	(9,151)
Acquisition of interests in non-controlling interests (Note 14)	(11,189)		(1,968)
Repayment of long-term borrowings (Note 13)	(8,716)	(14,128)	(87,008)
Long-term borrowings obtained (Note 13)	2,107	3,765	73,677
Sale of equity to non-controlling interest (Note 14)		1,407
Dividends paid to non-controlling interest		(1,024)
Payment of facility fee (Note 13)			(872)
Proceeds from bank overdraft			24,580
Repayment of bank overdraft			(23,335)
Net change in settlement obligations (Note 2)	(53,364)	33,870	(11,053)
NET CASH PROVIDED (USED IN) BY FINANCING ACTIVITIES	13,645	16,784	(25,781)
Effect of exchange rate changes on cash	(18,380)	(12,348)	2,880
NET INCREASE IN CASH AND CASH EQUIVALENTS	106,061	58,911	5,007
CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR	117,583	58,672	53,665
CASH AND CASH EQUIVALENTS AT END OF YEAR	$ 223,644	$ 117,583	$ 58,672